Skip to content
PoliticalRepoPoliticalRepo

Subjects · US

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

701 records in US in 2025

All countriesSearch this topic

Records

Bill· HRH.R. 4745 (119th)referred

Medicaid Bump Act

United States · United States Congress · 23 July 2025

Medicaid Bump Act This bill increases the Medicaid federal matching rate, also known as the Federal Medical Assistance Percentage (FMAP), for behavioral health expenses that exceed prior levels (i.e., as of March 31, 2019). The Centers for Medicare & Medicaid Services must specify which services are eligible for the increased FMAP. States must use funds to supplement state funding for programs in effect as of April 1, 2021, and to increase the capacity, efficiency, and quality of services.

Bill· HRH.R. 4708 (119th)referred

Spotted Lanternfly Research and Development Act

United States · United States Congress · 23 July 2025

Spotted Lanternfly Research and Development Act This bill includes combatting the spotted lanternfly (Lycorma delicatula) as a Department of Agriculture (USDA) high-priority research and extension area and reauthorizes other USDA research and extension initiatives. The bill specifically allows grants for developing and disseminating research-based tools and treatments to combat the spotted lanternfly, which is an invasive species native to Asia that feeds on a wide range of crops and plants (e.g., grapes, apples, hops, walnuts, and hardwood trees). Further, the bill reauthorizes USDA grants to support competitive specialized research and extension activities, including high-priority areas, through FY2030. The bill also specifically reauthorizes through FY2030 the Pulse Crop Health Initiative; the Comprehensive Food Safety Training Network; pollinator protection research and extension grants; increased USDA capacity and infrastructure to address and conduct research on colony collapse disorder and other pollinator issues; and a USDA-conducted nationwide honey bee pest, pathogen, health, and population status surveillance program.

Bill· HRH.R. 4721 (119th)referred

Healthy H2O Act

United States · United States Congress · 23 July 2025

Healthy Drinking Water Affordability Act or the Healthy H2O Act This bill directs the Department of Agriculture (USDA) to establish a program under which USDA awards grants for improving the quality of drinking water in certain rural areas. Grants may be given to individuals or entities, such as home owners, renters, and licensed child-care facilities, that have demonstrated the presence of one or more health contaminants in their drinking water. Grants may also be given to nonprofit organizations to help individuals and entities test their water, analyze the results of the tests, and reduce the contamination.

Bill· HRH.R. 4681 (119th)referred

SPARC Act

United States · United States Congress · 23 July 2025

Bill· HRH.R. 4641 (119th)referred

Keep Kids Covered Act

United States · United States Congress · 23 July 2025

Bill· HRH.R. 4731 (119th)referred

Resident Physician Shortage Reduction Act of 2025

United States · United States Congress · 23 July 2025

Resident Physician Shortage Reduction Act of 2025 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2026-FY2032; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.

Bill· HRH.R. 4725 (119th)referred

TRUTH in Labeling Act

United States · United States Congress · 23 July 2025

Resolution· HCONRESH.Con.Res. 46 (119th)referred

Expressing the sense of Congress that the United States is committed to ensuring a safe and healthy climate for future generations, and thus to restoring the climate.

United States · United States Congress · 23 July 2025

This resolution declares that climate restoration, along with achieving net-zero CO2 emissions, are climate policy priorities. It also urges the President, the Department of State, and the United Nations to take actions that will restore the climate and stabilize greenhouse gas concentrations at preindustrial levels.

Bill· HRH.R. 4722 (119th)referred

Urban Indian Health Parity Act

United States · United States Congress · 23 July 2025

Urban Indian Health Parity Act This bill applies a Federal Medical Assistance Percentage (i.e., the federal matching rate under Medicaid) of 100% with respect to amounts expended as medical assistance for services received through an Urban Indian organization under a grant or contract with the Indian Health Service.

Bill· HRH.R. 4606 (119th)referred

Ally’s Act

United States · United States Congress · 22 July 2025

Bill· HRH.R. 4623 (119th)referred

Plain Prescription Prices Act

United States · United States Congress · 22 July 2025

Plain Prescription Prices Act This bill requires the Centers for Medicare & Medicaid Services to issue a rule requiring direct-to-consumer television advertisements for prescription drugs that are covered by Medicare or Medicaid to include a textual statement of the drug's list price.

Bill· HRH.R. 4611 (119th)referred

EACH Act of 2025

United States · United States Congress · 22 July 2025

Bill· HRH.R. 4619 (119th)referred

Medicare Mental Health Inpatient Equity Act of 2025

United States · United States Congress · 22 July 2025

Medicare Mental Health Inpatient Equity Act of 2025 This bill removes the 190-day lifetime limit on inpatient psychiatric hospital services under Medicare.

Bill· SS. 2377 (119th)referred

EACH Act of 2025

United States · United States Congress · 22 July 2025

Bill· HRH.R. 4564 (119th)referred

Dillon’s Law

United States · United States Congress · 21 July 2025

Bill· HRH.R. 4552 (119th)open

Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026

United States · United States Congress · 21 July 2025

Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026 This bill provides FY2026 appropriations to the Department of Transportation (DOT), the Department of Housing and Urban Development (HUD), and several related agencies. The bill provides appropriations to DOT for the Office of the Secretary, the Federal Aviation Administration, the Federal Highway Administration, the Federal Motor Carrier Safety Administration, the National Highway Traffic Safety Administration, the Federal Railroad Administration, the Federal Transit Administration, the Great Lakes St. Lawrence Seaway Development Corporation, the Maritime Administration, the Pipeline and Hazardous Materials Safety Administration, and the Office of Inspector General. The bill provides appropriations to HUD for Management and Administration, Public and Indian Housing, Community Planning and Development, Housing Programs, the Federal Housing Administration, the Government National Mortgage Association (Ginnie Mae), Policy Development and Research, Fair Housing and Equal Opportunity, the Office of Lead Hazard Control and Healthy Homes, the Information Technology Fund, and the Office of Inspector General. The bill also provides appropriations to several related agencies, including the Access Board, the Federal Maritime Commission, the National Railroad Passenger Corporation (Amtrak) Office of Inspector General, the National Transportation Safety Board, the Neighborhood Reinvestment Corporation, and the Surface Transportation Board. Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations acts.

Bill· HRH.R. 4541 (119th)referred

To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.

United States · United States Congress · 17 July 2025

This bill reauthorizes and revises programs of the Centers for Disease Control and Prevention (CDC) that support services and education addressing breast and cervical cancer. The bill reauthorizes through FY2030 and makes changes to the CDC’s National Breast and Cervical Cancer Early Detection Program. This program provides grants to states for breast and cervical cancer screening, diagnostic, and treatment services for individuals who have low incomes, are uninsured, or otherwise lack access to such services. The bill increases flexibility in how states may spend grant funds under the program. The Government Accountability Office must report to Congress on the work of the National Breast and Cervical Cancer Early Detection Program, including the number of individuals served and barriers to accessing screenings. Also, the bill reauthorizes through FY2031 CDC programs relating to young women’s awareness of breast health and breast cancer. These programs include campaigns to educate young women and health care professionals, research on preventing breast cancer in younger women, and grants for resources and services to young women diagnosed with breast cancer and precancerous conditions.

Bill· HRH.R. 4484 (119th)referred

ADAPT Act

United States · United States Congress · 17 July 2025

Accelerating the Development of Advanced Psychology Trainees Act or the ADAPT Act This bill provides for Medicare coverage of services that are furnished by advanced psychology trainees. It also requires the Centers for Medicare & Medicaid Services to issue guidance for states on coverage options for such services under Medicaid and the Children's Health Insurance Program (CHIP).

Bill· HRH.R. 4488 (119th)referred

Veterans Health Care Stamp Act

United States · United States Congress · 17 July 2025

Veterans Health Care Stamp Act This bill requires the U.S. Postal Service to issue and sell a Veterans Health Care Stamp to help fund the medical care and treatment of veterans.

Bill· SS. 2323 (119th)open

HEADWAY Act

United States · United States Congress · 17 July 2025

Head start Education And Development Workforce Advancement and Yield Act or the HEADWAY Act This bill allows some teachers in Early Head Start programs to teach while in the process of earning their Child Development Associate (CDA) credential and completing training. Currently, the Department of Health and Human Services (HHS) must ensure that all teachers providing direct services to children and families in Early Head Start centers (1) have a minimum of a CDA credential and have been trained in early childhood development, and (2) have been trained in early childhood development with a focus on infant and toddler development. The bill revises this requirement by requiring at least one teacher per classroom (instead of all teachers) to have a CDA credential and training. In particular, the bill requires HHS to ensure that (1) each additional teacher providing direct services to children and families is in the process of earning a CDA credential and completing training, and (2) the Early Head Start agency provides a mentor to oversee the progress and guide the work of a teacher who is in the process of earning a CDA credential and completing training.

Bill· SS. 2356 (119th)referred

ADAPT Act

United States · United States Congress · 17 July 2025

Accelerating the Development of Advanced Psychology Trainees Act or the ADAPT Act This bill provides for Medicare coverage of services that are furnished by advanced psychology trainees. It also requires the Centers for Medicare & Medicaid Services to issue guidance for states on coverage options for such services under Medicaid and the Children's Health Insurance Program (CHIP).

Bill· SS. 2336 (119th)referred

Halting the Epidemic of Addiction and Loss Act of 2025

United States · United States Congress · 17 July 2025

Halting the Epidemic of Addiction and Loss Act of 2025 This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration. Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.

Bill· SS. 2345 (119th)referred

Short on Competition Act

United States · United States Congress · 17 July 2025

Short on Competition Act This bill requires the Food and Drug Administration (FDA) to provide temporary authorization to import certain prescription drugs facing shortages or in a marginally competitive drug market. Specifically, the FDA must authorize importation of an eligible drug that is lifesaving, life-sustaining, or intended to treat or prevent a debilitating condition. To be eligible, a drug must (1) be facing a shortage, (2) require a prescription, (3) have received market authorization in certain foreign countries, and (4) have the same active ingredient as the drug for which there is a shortage in the United States. The drug's manufacturer must also seek approval for the drug as a generic drug. The authority to import a drug terminates after three years or when the shortage no longer applies, whichever occurs first. Importation must begin within 60 days of the FDA receiving an application that meets all of the applicable requirements. The FDA may deny importation of a drug for reasons related to safety or effectiveness. Drugs in marginally competitive markets must be treated as being in shortage for the purposes of this bill and may be treated as such for the purposes of expediting inspections and reviewing applications. A drug is in a marginally competitive market if (1) there are fewer than five holders of approved applications for commercially available brand-name or generic versions of the drug, (2) the drug has been approved for at least 10 years, and (3) the patents on the drug's active ingredients have expired.

Bill· SS. 2339 (119th)open

EARLY Act Reauthorization of 2025

United States · United States Congress · 17 July 2025

EARLY Act Reauthorization of 2025 This bill reauthorizes through FY2031 programs relating to young women’s awareness of breast health and breast cancer, which are administered by the Centers for Disease Control and Prevention. These programs include campaigns to educate young women and health care professionals, research on preventing breast cancer in younger women, and grants for resources and services to young women diagnosed with breast cancer and precancerous conditions.

Bill· SS. 2341 (119th)referred

Ensuring Safe and Toxic-Free Foods Act of 2025

United States · United States Congress · 17 July 2025

Ensuring Safe and Toxic-Free Foods Act of 2025 This bill limits the circumstances in which a food additive may be considered generally recognized as safe (GRAS) and requires the Food and Drug Administration (FDA) to review the safety of all such additives. Under current law, food additives generally require pre-market FDA approval unless they are considered GRAS (generally recognized among qualified experts as safe for their intended use). When a manufacturer determines that an additive is GRAS, it may, but is not required to, notify the FDA of that determination. Under the bill, before an additive may be used in food, it must be (1) approved by the FDA, or (2) the subject of a GRAS notification submitted up to two years after the bill’s enactment to which the FDA has not objected. GRAS notifications submitted after enactment must include specified supporting information. The FDA must publish and seek public comment on such notifications. The FDA must ultimately publish a written determination stating whether it objects to the GRAS determination along with its reasoning. The FDA may also reassess GRAS notifications submitted before the bill’s enactment and require a manufacturer to submit the same supporting information required of post-enactment notifications. The FDA must annually review or reassess at least 50 GRAS notifications until all notifications have been reviewed or reassessed. Separately, the FDA must regularly reassess the safety of approved food additives and those considered GRAS. Finally, the bill makes toxic and carcinogenic substances ineligible to be considered GRAS.

Bill· SS. 2332 (119th)referred

ALERT Communities Act

United States · United States Congress · 17 July 2025

PreviousPage 14 of 15Next